BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas is a research paper published in New England Journal of Medicine (2023). On theSindex it has a DataRank of 4.5. It has been cited 138 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.740
From this paper's citation signal
Citation Network Contribution
3.8
From 76 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
National Cancer Institute
Grant: U10CA180821, U10CA180882, U24CA196171
National Cancer Institute
Grant: U10CA180868
National Cancer Institute
Grant: UG1CA232760, UG1CA233178, UG1CA233180, UG1CA23332
National Cancer Institute
Grant: UG1CA233331, UG1CA233339, UG1CA189824
NCI NIH HHS
Grant: UG1 CA233180
NCI NIH HHS
Grant: U24 CA196171
NCI NIH HHS
Grant: UG1 CA233178
NCI NIH HHS
Grant: UG1 CA233339
NCI NIH HHS
Grant: U10 CA180821
NCI NIH HHS
Grant: U10 CA180882
NCI NIH HHS
Grant: UG1 CA232760
NCI NIH HHS
Grant: UG1 CA233320
NCI NIH HHS
Grant: UG1 CA189824
NCI NIH HHS
Grant: U24 CA180803
NCI NIH HHS
Grant: UG1 CA233331
Genentech
FWCI
21.81
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals